Medulloblastoma: clinicopathological parameters, risk stratification, and survival analysis of immunohistochemically validated molecular subgroups.

Asmaa Mustafa EidNehal Abd El-Ghaffar Heabah

Published in: Journal of the Egyptian National Cancer Institute (2021)

Medulloblastoma classification based on molecular subgroups, together with clinicopathological indicators, mainly histopathological types; accurately risk stratifies MB patients and predicts their survival.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
machine learning
deep learning
prognostic factors
peritoneal dialysis
free survival
single molecule
patient reported outcomes